What is INCR's relative strength rating?

INCR ranks at the 77th percentile over 1 month, 85th percentile over 3 months, 80th percentile over 6 months, 22th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is INCR in?

INCR is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is INCR in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). INCR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is INCR?

INCR currently shows a 20-day average daily range (ADR%) of 6.1%, a 90-day beta versus the S&P 500 of 1.56. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does INCR have a seasonal pattern?

TickerStance computes INCR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what INCR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did INCR last report earnings?

No SEC EDGAR filings are linked to INCR in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Intercure Ltd. Ordinary Shares (INCR) · RS 80

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Intercure Ltd. Ordinary Shares (INCR) has a 3-month relative strength percentile of 85 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.1%, relative volume 10.98×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month85pctile

6 month80pctile

1 year22pctile

Classic49IBD pctile

LDR59leadership

0 of 5 lenses lit · avg RS pctile 59

✓ADR%6.1%!A/DD✓RVOL10.98×!$ Vol$135K

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2022

Best monthMay on averageavg +7.56% · 60% win · n 5

Worst monthOct on averageavg -14.41% · 25% win · n 4

INCR monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	INCR Jan avg: 1.74% median: 1.97% win: 75% σ: 8.19% n: 4 2022-04-12 → 2026-07-31	INCR Feb avg: 4.44% median: -7.30% win: 25% σ: 42.36% n: 4 2022-04-12 → 2026-07-31	INCR Mar avg: 0.50% median: -9.78% win: 25% σ: 25.90% n: 4 2022-04-12 → 2026-07-31	INCR Apr avg: 7.28% median: 12.09% win: 80% σ: 10.00% n: 5 2022-04-12 → 2026-07-31	INCR May avg: 7.56% median: 1.03% win: 60% σ: 22.01% n: 5 2022-04-12 → 2026-07-31	INCR Jun avg: -13.80% median: -10.23% win: 0% σ: 10.35% n: 5 2022-04-12 → 2026-07-31	INCR Jul avg: -2.28% median: -2.72% win: 40% σ: 8.11% n: 5 2022-04-12 → 2026-07-31	INCR Aug avg: 0.87% median: 2.46% win: 75% σ: 9.38% n: 4 2022-04-12 → 2026-07-31 (current)	INCR Sep avg: -5.78% median: -6.97% win: 25% σ: 7.88% n: 4 2022-04-12 → 2026-07-31	INCR Oct avg: -14.41% median: -14.53% win: 25% σ: 17.47% n: 4 2022-04-12 → 2026-07-31	INCR Nov avg: -0.61% median: -0.77% win: 50% σ: 18.40% n: 4 2022-04-12 → 2026-07-31	INCR Dec avg: -10.26% median: -13.56% win: 50% σ: 26.63% n: 4 2022-04-12 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

3 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

77

3m

85

6m

80

1y

22

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

D

RVOL todayvs 50d avg

10.98×

U/D ratiolast 50 sessions

0.96

Breakout volbreakout day vs 50d avg

+1589%

50d avg $ volumeliquidity proxy

$135K

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

6.1%Elevated

ATR(14)14-day EMA

$0.38

ATR%ATR as % of close

6.92%

Beta vs SPY90d rolling

1.56

1-ADR stoprisk from close $5.48

$5.15−6.1%

Fundamentals · INCR

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
INCR
85RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials55

Real Estate45

Consumer Staples36

RS pctileLagLead

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

CRONCronos Group Inc. Common Share80 OPKOpko Health Inc.80 IMNMImmunome, Inc.80 ACETAdicet Bio, Inc. Common Stock80

Public attention · INCR

Is the crowd watching?

60/ 100 · vs its own 90-day norm▲ 4 vs 7dLate-cycle leader

Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float37.1Mshares

Shares out11.8Mshares

Market cap$64.9MMicro Cap

FAQ

Frequently asked questions

What is INCR's relative strength rating?: INCR ranks at the 77th percentile over 1 month, 85th percentile over 3 months, 80th percentile over 6 months, 22th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is INCR in?: INCR is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is INCR in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). INCR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is INCR?: INCR currently shows a 20-day average daily range (ADR%) of 6.1%, a 90-day beta versus the S&P 500 of 1.56. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does INCR have a seasonal pattern?: TickerStance computes INCR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what INCR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did INCR last report earnings?: No SEC EDGAR filings are linked to INCR in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Intercure Ltd. Ordinary Shares (INCR) — Stance & relative strength

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Intercure Ltd. Ordinary Shares (INCR) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

§ Seasonality

Intercure Ltd. Ordinary Shares (INCR) — Stance & relative strength

INCR is on the watchlist, not confirmed. 3m RS is 85, Market Stance is mixed at 47.8, A/D rating D

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Intercure Ltd. Ordinary Shares (INCR) — Stance & relative strength

INCR is on the watchlist, not confirmed. 3m RS is 85, Market Stance is mixed at 47.8, A/D rating D

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions